World Multiple Sclerosis Market to Amount to USD 17.3 Billion in 2016, Expects FirstWord
19 Nov 2012 • by Natalie Aster
The global multiple sclerosis (MS) market is set to grow from $12.3 billion in 2011 to $17.3 billion in 2016. Primary drivers of this growth will be the entry of new pipeline therapies, satisfying unmet needs of convenient administration and more efficacious therapy, and continued uptake of existing therapies.
“Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules” report by FirstWord comes in two modules.
Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules
Published: September, 2012
Price: US$ 7.495,00
KOL Insight provides concise, qualitative KOL analysis of the current and predicted treatment trends, clinical products, and commercial changes in the global sector provided by 8-12 of the field’s foremost key opinion leaders.
Consensus Outlook provides an in-depth 5-year report of the predicted quantitative changes in key market forecast parameters. This module provides access to various charts including market size, product sales, market share by company, competitive status, and detailed market forecasts.
KOL Insight: Multiple Sclerosis will help to:
- Understand the key unmet needs of the MS market
- Identify how therapies will be positioned against each other in future treatments
- Interpret the potential for new players in the lucrative MS market
Consensus Outlook: Multiple Sclerosis will help to:
- Evaluate future sales forecast and predicted market growth for MS products
- Assess MS market share by company and product
- Determine your market value over the next 5 years
More information can be found in the report “Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules” by FirstWord.
To order the report or ask for sample pages contact [email protected]